Concourse Financial Group Securities’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-517
| Closed | -$1.18K | – | 10297 |
|
|
2024
Q2 | $1.18K | Hold |
517
| – | – | ﹤0.01% | 2100 |
|
|
2024
Q1 | $2.23K | Hold |
517
| – | – | ﹤0.01% | 2033 |
|
|
2023
Q4 | $1.58K | Hold |
517
| – | – | ﹤0.01% | 2051 |
|
|
2023
Q3 | $744 | Hold |
517
| – | – | ﹤0.01% | 2133 |
|
|
2023
Q2 | $1.29K | Hold |
517
| – | – | ﹤0.01% | 2093 |
|
|
2023
Q1 | $1.39K | Hold |
517
| – | – | ﹤0.01% | 2116 |
|
|
2022
Q4 | $2.81K | Hold |
517
| – | – | ﹤0.01% | 1978 |
|
|
2022
Q3 | $6K | Hold |
517
| – | – | ﹤0.01% | 1625 |
|
|
2022
Q2 | $3K | Hold |
517
| – | – | ﹤0.01% | 1988 |
|
|
2022
Q1 | $4K | Hold |
517
| – | – | ﹤0.01% | 1923 |
|
|
2021
Q4 | $5K | Hold |
517
| – | – | ﹤0.01% | 2062 |
|
|
2021
Q3 | $7K | Hold |
517
| – | – | ﹤0.01% | 2000 |
|
|
2021
Q2 | $11K | Hold |
517
| – | – | ﹤0.01% | 1851 |
|
|
2021
Q1 | $12K | Buy |
+517
| New | +$12K | ﹤0.01% | 1722 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 6699 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 6467 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 6309 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 6206 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 6115 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 5961 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 5965 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 5856 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 5772 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 5616 |
|